Joaquim Calado
Department of Genetics
Faculty of Medical Sciences
New University of Lisbon
Lisbon
Portugal
Name/email consistency: high
- Effect of kidney disease on glucose handling (including genetic defects). Calado, J., Santer, R., Rueff, J. Kidney Int. (2011)
- Dapagliflozin, an oral sodium glucose cotransporter type 2 inhibitor for the treatment of type 2 diabetes mellitus. Calado, J. IDrugs (2009)
- Twenty-one additional cases of familial renal glucosuria: absence of genetic heterogeneity, high prevalence of private mutations and further evidence of volume depletion. Calado, J., Sznajer, Y., Metzger, D., Rita, A., Hogan, M.C., Kattamis, A., Scharf, M., Tasic, V., Greil, J., Brinkert, F., Kemper, M.J., Santer, R. Nephrol. Dial. Transplant. (2008)
- Familial renal glucosuria: SLC5A2 mutation analysis and evidence of salt-wasting. Calado, J., Loeffler, J., Sakallioglu, O., Gok, F., Lhotta, K., Barata, J., Rueff, J. Kidney Int. (2006)
- A novel heterozygous missense mutation in the UMOD gene responsible for Familial Juvenile Hyperuricemic Nephropathy. Calado, J., Gaspar, A., Clemente, C., Rueff, J. BMC Med. Genet. (2005)
- Novel compound heterozygous mutations in SLC5A2 are responsible for autosomal recessive renal glucosuria. Calado, J., Soto, K., Clemente, C., Correia, P., Rueff, J. Hum. Genet. (2004)
- Gene Symbol: SLC55A2. Disease: familial renal glucosuria. Calado, J., Soto, K., Clemente, C., Correia, P., Rueff, J. Hum. Genet. (2004)
